Tyler Newton - Mar 5, 2025 Form 4 Insider Report for Weave Communications, Inc. (WEAV)

Role
Director
Signature
/s/ Alan Taylor, as Attorney-in-Fact
Stock symbol
WEAV
Transactions as of
Mar 5, 2025
Transactions value $
$0
Form type
4
Date filed
3/7/2025, 07:16 PM
Previous filing
Dec 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WEAV Common Stock Gift $0 -153K -50% $0.00 153K Mar 5, 2025 By Tyler Newton Revocable Trust F1
transaction WEAV Common Stock Gift $0 +153K $0.00 153K Mar 5, 2025 By Mia Newton Revocable Trust F1
holding WEAV Common Stock 74.1K Mar 5, 2025 See footnotes F2, F3, F4
holding WEAV Common Stock 74.1K Mar 5, 2025 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 5, 2025, the Reporting Person transferred, for no consideration, (i) 152,978 shares of the Issuer's common stock to the Tyler Newton Revocable Trust (the "Tyler Trust"), and (ii) 152,978 shares of the Issuer's common stock to the Mia Newton Revocable Trust (the "Mia Trust", and together with the Tyler Trust, the "Newton Trusts"). The Reporting Person is the trustee of the Tyler Trust, and the Reporting Person's wife is the trustee of the Mia Trust. The Newton Trusts are living trusts of which the Reporting Person, his wife and members of his immediate family are the beneficiaries. The Reporting Person disclaims beneficial ownership of the securities held by the Newton Trusts except to the extent of his pecuniary interest in such securities.
F2 The Reporting Person is a direct and/or indirect investor in Catalyst Investors IV, L.P. (the "CIIV Fund") and Catalyst Investors QP IV, L.P. (the "CIQP Fund," and, together with the CIIV Fund, the "CI Funds"). Catalyst Investors Partners IV, L.P. (the "CIPIV GP") serves as the general partner of each of the CI Funds. Catalyst Investors Partners IV, L.L.C. (the "CI LLC GP", and together with the CIPIV GP, the CIIV Fund, and the CIQP Fund, the "CI Entities") is the general partner of CIPIV GP.
F3 Held by the CIQP Fund.
F4 The Reporting Person's interest in the Issuer's securities is limited to the extent of the Reporting Person's pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by any Reporting Person, the CI Entities, or any other person/entity that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
F5 Represents restricted stock units (the "RSUs") granted to the Reporting Person. The Reporting Person is holding the RSUs for the benefit of one or more of the CI Funds. Of the 74,097 RSUs, 54,714 RSUs have vested, and the balance, 19,383 RSUs, will vest on the earlier of (a) May 22, 2025 and (b) the date of the first annual meeting of the Issuer's stockholders following May 22, 2024. Each RSU, upon vesting, is exchangeable for one share of the Issuer's common stock.